IDEXX officer Underberg proposes $6.13M share sale
The shares are listed as acquired from the issuer through a stock option exercise, with cash payment, on November 4, 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Sharon E. Underberg, an officer of IDEXX Laboratories (IDXX), reported a proposed sale of 8,906 common shares through broker Morgan Stanley Smith Barney LLC. The listed aggregate market value is $6,132,605.70, and November 4, 2026 is the approximate sale date. The notice also lists 8,906 common shares acquired from the issuer through a stock option exercise on November 4, 2026, with cash payment. The table lists 78,786,265 common shares outstanding.
Key Figures
Key Terms
Rule 144 regulatory
person regulatory
Stock Option Exercise financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.